<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Long-chain PUFAs, including EPA and DHA, are reported to have a therapeutic role in a variety of inflammatory pathologies, such as Alzheimer’s disease, arthritis, and lupus [
 <xref rid="B240-marinedrugs-17-00304" ref-type="bibr" class="xref">240</xref>]. A growing number of studies in animal and in vitro trials support the anti-inflammatory properties of microalgal oils. Nauroth et al. [
 <xref rid="B86-marinedrugs-17-00304" ref-type="bibr" class="xref">86</xref>] reported that the use of docosapentaenoic acid (DPA), another omega-3 PUFA, from 
 <italic class="italic">Schizochytrium</italic> sp. inhibited the lipopolysaccharide (LPS)-stimulated secretion of interleukin (IL)-1 beta and tumor necrosis factor-alpha (TNF-α) in human peripheral blood mononuclear cells. The authors also found that rats fed an algal oil containing DPA (16% of the total fatty acids) and DHA (40% of the total fatty acids) significantly reduced inflammation in paw edema model rats in comparison to the control [
 <xref rid="B86-marinedrugs-17-00304" ref-type="bibr" class="xref">86</xref>]. Banskota et al. [
 <xref rid="B241-marinedrugs-17-00304" ref-type="bibr" class="xref">241</xref>,
 <xref rid="B242-marinedrugs-17-00304" ref-type="bibr" class="xref">242</xref>] also reported anti-inflammatory effects in RAW 264.7 macrophage cells from lipid extracts containing monogalactosyldiacylglycerols from 
 <italic class="italic">Tetraselmis chuii</italic>, 
 <italic class="italic">Chlorella sorokiniana</italic>, and 
 <italic class="italic">Chondrus crispus</italic>. Furthermore, the use of microalgal oils in the diet, especially those that are rich in omega-3 fatty acids, has been demonstrated to induce chemopreventative effects on azoxymethane-induced colonic aberrant crypt foci functions [
 <xref rid="B243-marinedrugs-17-00304" ref-type="bibr" class="xref">243</xref>].
</p>
